Skip to main content
. 2020 Apr 24;9(4):1233. doi: 10.3390/jcm9041233

Figure 3.

Figure 3

Evolution of Lam-P1 levels (log transformed) in the three therapeutic arms. Lam-P1 levels significantly decrease in type 2 diabetes mellitus patients treated with somatostatin. Lam-P1: laminin P1; BRIM: brimonidine; SST: somatostatin. * p < 0.001 between Baseline and Month 6. # p = 0.043 between Month 6 and Month 12.